Forzaten-HCT 40 mg - 5 mg - 12.5 mg (olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochloorthiazide 12,5 mg tablet (or.)) · CNK 2837326

Product information

Product name
Forzaten-HCT 40 mg - 5 mg - 12.5 mg
Pack
98
Active ingredient
olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochloorthiazide 12,5 mg tablet (or.)
CNK Code
2837326
Availability score
0 / 10
Historic availability score
Locked

Product properties

CAS code
144689-63-4
ATC code
C09DX03
Company
Menarini International Operations Luxembourg
Pharmaceutical form
Film-coated tablet
Ex-factory price
€27.34
Authorisation number
BE390564
GTIN
05400835000742
Delivery mode
M1
Delivery environment
Public
CTI Extended
390564-07

Pharmacist Assessment

Assessment title
Not available
Assessment description

This product is officially temporarily unavailable (reason: Other reason) and is no longer being supplied in practice (score 0/10). Switch to an alternative.

Recommended alternative

Assessment alternative
Sevikar-HCT 40 mg - 5 mg - 12.5 mg (CNK 2816635) — Score: 5.21/10

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives
Magistral alternative available 2

Status history (PharmaStatus)

Temporarily unavailable
-

Other reason

In principle, sufficient stock in circulation (short term)

Composition

3 ingredients

Ingredients
Substance Type Strength CAS
Substance
Olmesartanmedoxomil
Type
Active ingredient
Strength
40 mg
CAS
144689-63-4
Substance
Hydrochloorthiazide
Type
Active ingredient
Strength
12.5 mg
CAS
58-93-5
Substance
Amlodipinebesilaat
Type
Active ingredient
Strength
6.944 mg
CAS
111470-99-6

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Temporarily unavailable
Days unavailable (last year)
115 days
Number of status changes
6
Active supply problems
1
Last change
10/07/2026